XML 120 R15.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

Accrued Expenses and Other Current Liabilities | 12 Months Ended
--- | ---
Dec. 31, 2023
Schedule of Accrued Expenses and Other Current Liabilities [Abstract] |
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES | 8. ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES Accrued expenses and other current liabilities consisted of the following as of the periods indicated:
|  | December 31, |  |  | December 31, |
|  | 2023 |  |  | 2022 |
Accrued research and development expense |  | $ | 1,799,583 |  |  | $ | 1,600,221 |
Accrued compensation and employee benefits |  |  | 1,184,505 |  |  |  | 568,865 |
Accrued royalties |  |  | 274,028 |  |  |  | 272,352 |
Others |  |  | 438,264 |  |  |  | 468,150 |
Total |  | $ | 3,696,380 |  |  | $ | 2,909,587 |

X
- Definition The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19(a),20,24) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration